Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Mar:37:102678.
doi: 10.1016/j.pdpdt.2021.102678. Epub 2021 Dec 8.

Phototherapies for COVID-19-associated opportunistic oral infections

Affiliations
Case Reports

Phototherapies for COVID-19-associated opportunistic oral infections

Giuseppina Berlingieri et al. Photodiagnosis Photodyn Ther. 2022 Mar.

Abstract

Opportunistic infections are widely described in patients with novel coronavirus disease 2019 (COVID-19); however, very few studies have addressed those affecting the oral cavity. Given the lack of information on the clinical presentations and the available treatment options, the present study aimed to show a case in which a combination of antimicrobial photodynamic therapy (aPDT) and photobiomodulation therapy (PBMT) was used for the management of two concomitant COVID-19-associated opportunistic oral infections (oral pseudomembranous candidiasis and recurrent herpes labialis). Within 7 days and without any systemic drug administration, all the lesions resolved completely, and the patient no longer reported oral pain or discomfort. According to the current case report and taking into consideration the significant gaps in the knowledge and understanding of COVID-19, this combination of phototherapy modalities seems to be a promising tool for managing viral and fungal opportunistic oral infections.

Keywords: Antimicrobial photodynamic therapy; COVID-19; Candidiasis; Herpes Labialis; Photobiomodulation therapy; SARS-CoV-2.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Clinical appearance: oral pseudomembranous candidiasis and recurrent herpes labialis lesions. A, B. At diagnosis; C,D. 72 h after the first laser session; E,F. 7 days after the first laser session, showing the lesions completely resolved.

References

    1. Ezeokoli O.T., Pohl C.H. Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: are they risk factors for disease severity? South African Med. J. 2020;110:1081. doi: 10.7196/SAMJ.2020.v110i11.15248. - DOI - PubMed
    1. Zhang H., Zhang Y., Wu J., Li Y., Zhou X., Li X., Chen H., Guo M., Chen S., Sun F., Mao R., Qiu C., Zhu Z., Ai J., Zhang W. Risks and features of secondary infections in severe and critical ill COVID-19 patients. Emerg. Microbes Infect. 2020;9:1958–1964. doi: 10.1080/22221751.2020.1812437. - DOI - PMC - PubMed
    1. Abdoli A., Falahi S., Kenarkoohi A. COVID-19-associated opportunistic infections: a snapshot on the current reports. Clin. Exp. Med. 2021 doi: 10.1007/s10238-021-00751-7. - DOI - PMC - PubMed
    1. Teixeira I.S., Leal F.S., Tateno R.Y., Palma L.F., Campos L. Photobiomodulation therapy and antimicrobial photodynamic therapy for orofacial lesions in patients with COVID-19: a case series. Photodiagnosis Photodyn. Ther. 2021;34 doi: 10.1016/j.pdpdt.2021.102281. - DOI - PMC - PubMed
    1. Ramires M.C.C.H., Mattia M.B., Tateno R.Y., Palma L.F., Campos L. A combination of phototherapy modalities for extensive lip lesions in a patient with SARS-CoV-2 infection. Photodiagnosis Photodyn. Ther. 2021;33 doi: 10.1016/j.pdpdt.2021.102196. - DOI - PMC - PubMed

Publication types

Substances